Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses

Several approaches have produced an effective vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since millions of people are exposed to influenza virus and SARS-CoV-2, it is of great interest to develop a two-in-one vaccine that will be able to protect against infection o...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Ramireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, Pratima Kumari, Luis E. Munoz, Judy Oh, Ki-Hye Kim, Jameson T. L. Berry, Kristen M. Jacobsen, Lahcen Jaafar, Swe-Htet Naing, Allison N. Blackerby, Tori Van der Gaag, Chloe N. Wright, Lilin Lai, Christopher D. Pack, Sampath Ramachandiran, Mehul S. Suthar, Sang-Moo Kang, Mukesh Kumar, Shaker J. C. Reddy, Periasamy Selvaraj
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Subjects:	influenza virus-like particles SARS-CoV-2 GM-CSF RBD mice
Online Access:	https://www.mdpi.com/2076-393X/10/6/944